SYNDAX PHARMACEUTICALS INC (SNDX) Stock Cash Flow
NASDAQ:SNDX - Nasdaq - US87164F1057 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -297.06M | -209.36M | -149.34M | 24.93M | -73.16M | |||
| Depreciation Amortization | 10.00K | 12.00K | 30.00K | 40.00K | 90.00K | |||
| Change In Working Capital | 12.09M | 31.86M | 1.66M | -9.60M | -7.93M | |||
| Interest Paid | 0.00 | 0.00 | 2.06M | 2.00M | 1.63M | |||
| Other non cash items | 26.09M | 16.89M | 13.97M | 13.76M | 9.74M | |||
| OPERATING CASH FLOW | -258.87M | -160.60M | -133.68M | 29.13M | -71.26M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | 0.00 | -130.00K | N/A | |||
| Other Investing Activity | 32.91M | 117.61M | -186.19M | -40.74M | -142.53M | |||
| INVESTING CASH FLOW | 32.91M | 117.61M | -186.19M | -40.87M | -142.53M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -21.00M | 0.00 | 19.73M | |||
| Stock Issued/Repurchased | 264.42M | 264.13M | 193.25M | 93.04M | 284.69M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | 25.42M | 0.00 | |||
| FINANCING CASH FLOW | 264.42M | 264.13M | 172.25M | 118.46M | 304.42M | |||
| CHANGE IN CASH | 38.47M | 221.14M | -147.62M | 106.72M | 90.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -258.87M | -160.60M | -133.68M | 29.13M | -71.26M | |||
| Capital Expenditure | N/A | 0.00 | 0.00 | -130.00K | N/A | |||
| FREE CASH FLOW | -258.87M | -160.60M | -133.68M | 29.00M | -71.26M | |||
All data in USD